Diagnosis, treatment, and nursing management of the patient with hemochromatosis.
Hemochromatosis results when the body's iron stores progressively increase. Surplus iron stored in body tissues leads to organ dysfunction and death. Warnings that elevated iron stores increase the risk of cancer development necessitate a review of this condition. Two types of hemochromatosis, hereditary and secondary, are diagnosed in today's hematology-oncology practices. Distinguishing the differences with respect to etiology and management is essential to the risk assessment and long-term nursing management of this patient population.
Keller
J F
JF
Haematology-Oncology Associates, Inc., Toledo, OH.
Blausey
L A
LA
D001803:Blood Transfusion / Q000592:standards; D001815:Bloodletting / Q000592:standards; D002614:Chelating Agents / Q000627:therapeutic use; D002985:Clinical Protocols / Q000592:standards; D003663:Decision Trees; D006432:Hemochromatosis / Q000175:diagnosis / Q000451:nursing* / Q000628:therapy; D006801:Humans; D010347:Patient Care Planning; D016896:Treatment Outcome
D002614:Chelating Agents